WCM Equity Research
Contributor since: 2018
Company: WCM Equity Research
Latest Articles
Don't Count Voclosporin Ophthalmic Solution Out
Krystal Biotech: An Intriguing Gene Therapy Platform Play
Assessment Of The Trade War
Fibrocell Science: An Underappreciated Gene Therapy Play
Take Advantage Of Poor Market Sentiment And Buy Esperion Therapeutics
Elucidating The Impact Of Alarm.com's Recent Homebuilder Partnership Program
Unfounded Reaction To Analysts' Regrades
Stamps.com: Materializing Business Strategy Meets Strong E-Commerce Growth
Alarm.com: Saturation Of Equity For An Unsaturated Market
Decoding Activision Blizzard's Call Of Duty Game-Play Reveal
Adjusted Price Targets For This Bio-Pharmaceutical Holding Company: More Than 20% Upside
Sangamo Therapeutics: Deciphering Valuation In The Face Of Key De-Risking Events
Innoviva Inc.: Buy This Small-Cap Biopharma Royalty Holding Company With 50% Upside
Aptose Biosciences: An In-Depth Look At Valuation
Cognitive Easing: Conviction In Monetary Policy
Aurinia Pharmaceuticals' Voclosporin: A Blockbuster Drug Hidden In Plain Sight?
Could CohBar Inc. Hold The Key To Treating Age-Related Disease?
Expiration Eve: Bitcoin Correction Thesis